When combined with PTM signaling activity analysis (Fig. 4C–E), these results suggest that colorectal cancer PDOs induce patient-specific rewiring of stIL15-γδ T-cell PTM signaling networks during AIC immunomodulation, and this is unchanged by anti-B7-H3 ADCC. Here, CD276 is linked to colorectal cancer.